Amoy Diagnostics Teams Up with Boehringer Ingelheim for CDx Developmen
Amoy Diagnostics Co., Ltd (AmoyDx, SHE: 300685), a prominent player in China’s tumor precision medicine...
Deals
AI in Pharma: MindRank Ltd Joins Forces with Zhejiang Hisun Pharmaceutical for Drug R&D
MindRank Ltd, a China-based artificial intelligence (AI)-driven drug development company, has entered into a strategic...
Henlius Biotech and Palleon Pharmaceuticals Modify Licensing Agreement for Bifunctional Antibody
Shanghai Henlius Biotech Inc., (HKG: 2696), a leading biopharmaceutical company based in China, has announced...
Astellas Pharma Considers Joint Cell Therapy Platform with Yaskawa Electric
Astellas Pharma Inc. (TYO: 4503), a leading Japanese pharmaceutical company, has announced that it is...
Sanofi Leads Pharma Industry with AI Collaboration with Formation Bio and OpenAI
Sanofi (NASDAQ: SNY), the France-based multinational pharmaceutical company, has announced a cutting-edge collaboration with US...
Blue Sail Medical Subsidiary Secures RMB 100 Million Investment to Expand Operations
China’s Blue Sail Medical Co., Ltd (SHE: 002382) has announced that Blue Sail Biosensors Medical...
Jiayue Pharmaceutical’s JYP0015 Secures $365 Million Licensing Agreement with Erasca
Guangzhou Jiayue Pharmaceutical Technology Co., Ltd, a Chinese pharmaceutical company, has entered into a licensing...
Pharmaron and AstraZeneca Enter Sweeping Partnership to Span Drug Development Services
Pharmaron Beijing Co., Ltd, a leading Contract Research Organization (CRO) based in Beijing (HKG: 3759;...
Union Hospital Teams Up with Baidu Health for AI-Enhanced Outpatient Services
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, has entered into a...
Pharmaron to Sell Proteologix Stake in Upcoming Johnson & Johnson Acquisition
Pharmaron Beijing Co., Ltd, a leading Contract Research Organization (CRO) based in Beijing (HKG: 3759;...
Fosun Pharma Nods to Fosun Health Spin-Off; IPO Venue and Requirements Under Review
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), a leading pharmaceutical company in...
Zhejiang Huahai Pharmaceutical Co., Ltd Plans Capital Raise for Digital Manufacturing Expansion
Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521), a leading Chinese pharmaceutical company, has unveiled plans...
Porton Biologics and SAFE Collaborate to Accelerate Pharmaceutical R&D Services
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
Biocytogen Expands Reach to India with GVSAP Partnership for BioMice Models
A recent stock exchange announcement from China-based Biocytogen (HKG: 2315) has highlighted a strategic partnership...
Sol-Gel Technologies Partners with Shenzhen Beimei for Twyneo Commercialization in China
Israel-based dermatology specialist Sol-Gel Technologies Ltd. (NASDAQ: SLGL) has announced the signing of a licensing...
J&J Acquires Immune-Mediated Diseases Specialist Proteologix in a Deal Worth Up to USD 850 Million
Johnson & Johnson (J&J; NYSE: JNJ), a global healthcare giant, has announced a deal to...
Huaixi Medical and Beijing HumaDX Tech Join Forces to Boost In Vitro Diagnostics
Huaixi Medical, a Nanjing-based specialist in flow cytometry, has entered into a strategic partnership with...
Merck KGaA Subsidiary Teams Up with Aulos Bioscience to Test PD-L1 and Anti-IL-2 Combination
Germany’s Merck KGaA (ETR: MRK) has announced that its Switzerland-based subsidiary, Ares Trading, has entered...
Hengrui Pharmaceuticals Strikes Deal with Hercules CM Newco to Supply GLP-1 Products for Global Markets
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading Chinese pharmaceutical company, has entered into...
Novo Holdings Gains Controlling Interest in Biopharma Equipment Supplier Single Use Support
Novo Nordisk’s (CPH: NOVO-B) controlling shareholder, Novo Holdings, has entered into an agreement to purchase...